Approvals/TGA/KIVEXA abacavir 600 mg (as sulfate) and lamivudine 300 mg tablet blister pack

Approved

STANDARD

KIVEXA abacavir 600 mg (as sulfate) and lamivudine 300 mg tablet blister pack

ViiV Healthcare Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: cf1ea1ce34ad631b
Product Name: KIVEXA abacavir 600 mg (as sulfate) and lamivudine 300 mg tablet blister pack
Artg Id: 99090
Artg Name: KIVEXA abacavir 600mg (as sulfate) and lamivudine 300mg tablet blister pack
Sponsor: ViiV Healthcare Pty Ltd
Company Detail Path: /organization/viiv-healthcare-pty-ltd
Artg Date: 2005-03-24
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/629f82543aecdd7fdd070bbac072a646.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/dc5085c75b5d8f09500188cfed35808b.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

cf1ea1ce34ad631b

Type

Standard